News Release

March 21, 2018

Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast

NASDAQ, TSX: NVCN

VANCOUVER, March 21, 2018 /CNW/ – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it will report financial results for the year ended December 31, 2017 and host a conference call and webcast at 4:30pm Eastern Time on Wednesday, March 28, 2018.

Conference Call & Webcast
Wednesday, March 28th @ 4:30pm Eastern Time

Domestic:                                

800-281-7973

International:                            

323-794-2093

Passcode:                               

4395026

Webcast:                                 

http://public.viavid.com/index.php?id=128910

Replays available through April 10:

Domestic:                                

844-512-2921

International:                            

412-317-6671

Conference ID:                         

4395026

 

About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™, for the treatment of refractory angina, which is not currently available in the United States and has been available in Europe since 2015, and the Tiara™, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada and Europe.  For more information, visit: www.neovasc.com.

SOURCE Neovasc Inc.